CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on September 7, 2007 under Uncategorized | Be the First to Comment
Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies.
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation.